Swedish Pharmaceuticals & Biotech Top Stock Picks from Analysts

Vitrolife

Market Cap: SEK 17.5b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

Hansa Biopharma

Market Cap: SEK 3.3b

A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.

Vicore Pharma Holding

Market Cap: SEK 2.9b

A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.

Xspray Pharma

Market Cap: SEK 2.4b

A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.

Egetis Therapeutics

Market Cap: SEK 1.9b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

BioInvent International

Market Cap: SEK 1.9b

A clinical-stage company, discovers and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.

Saniona

Market Cap: SEK 1.7b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.

Diamyd Medical

Market Cap: SEK 1.5b

Develops precision medicine therapies for the treatment of autoimmune diabetes.

Genovis AB (publ.)

Market Cap: SEK 1.5b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

BICO Group

Market Cap: SEK 1.5b

Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.

Cinclus Pharma Holding

Market Cap: SEK 746.5m

A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.

Xbrane Biopharma

Market Cap: SEK 652.7m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

Cantargia

Market Cap: SEK 643.9m

A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.

FluoGuide

Market Cap: SEK 524.4m

A clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark.

Guard Therapeutics International

Market Cap: SEK 461.8m

A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.

Ascelia Pharma

Market Cap: SEK 402.0m

A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.

Magle Chemoswed Holding

Market Cap: SEK 398.5m

Engages in research and development of pharmaceutical and medical device products in Sweden.

Intervacc

Market Cap: SEK 348.3m

Develops novel veterinary vaccines for animals in Sweden.

Mendus

Market Cap: SEK 339.9m

A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.

Curasight

Market Cap: DKK 222.0m

Develops therapeutic and diagnostic solutions for the treatment of cancer.

AlzeCure Pharma

Market Cap: SEK 293.0m

Operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.

IRLAB Therapeutics

Market Cap: SEK 253.1m

IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other CNS disorders.

Lipum

Market Cap: SEK 247.1m

A biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden.

Karolinska Development

Market Cap: SEK 245.3m

A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.

Initiator Pharma

Market Cap: SEK 236.2m

A clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system.

Elicera Therapeutics

Market Cap: SEK 235.4m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

Isofol Medical

Market Cap: SEK 227.7m

Operates as a clinical stage biotech company.

Annexin Pharmaceuticals

Market Cap: SEK 201.9m

A biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.

Active Biotech

Market Cap: SEK 199.0m

A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.

Alligator Bioscience

Market Cap: SEK 175.3m

A research-based biotechnology company, develops antibody-based pharmaceuticals for cancer treatment in Finland and Sweden.

Medivir

Market Cap: SEK 174.3m

A pharmaceutical company, focuses on the development and commercialization of treatments for cancer in Nordic region, rest of Europe, and internationally.

Biovica International

Market Cap: SEK 167.9m

A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.

Klaria Pharma Holding AB (publ.)

Market Cap: SEK 127.4m

A pharmaceutical company develops and commercializes medication for migraine and cancer related pain, and opioid overdose and anaphylactic shock.

Alzinova

Market Cap: SEK 125.2m

A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.

Biosergen

Market Cap: SEK 123.5m

A biotech company, develops antifungal products.

NextCell Pharma

Market Cap: SEK 107.5m

A biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden.